Table Of Contents
1 Introduction 17
1.1 Objectives Of The Study 17
1.2 Market Definition 17
1.3 Overview Of Europe Transradial Access Market 17
1.4 Currency And Pricing 18
1.5 Limitation 18
1.6 Markets Covered 19
2 Market Segmentation 21
2.1 Markets Covered 21
2.2 Geographic Scope 22
2.3 Years Considered For The Study 23
2.4 Currency And Pricing 23
2.5 Research Methodology 24
2.6 Primary Interviews With Key Opinion Leaders 27
2.7 Secondary Sources 28
2.8 Assumptions 28
3 Market Overview 29
3.1 Drivers 31
3.1.1 Increasing Cases Of Obese Patients 31
3.1.2 Rising Number Of Heart Problems 32
3.1.3 Growing Use Of Radial Access In Oncology Field 33
3.1.4 Technological Adavancements 34
3.2 Restraints 35
3.2.1 Product Recalls And Failures 35
3.3 Opportunities 36
3.3.1 Emerging Markets 36
3.4 Challenges 37
3.4.1 Side Effects Of Transradial Access 37
3.4.2 Lack Of Skilled Professsionals 37
4 Executive Summary 38
5 Premium Insights 40
6 Europe Transradial Access Market, By Product 49
6.1 Overview 50
6.2 Sheaths And Sheath Introducers 52
6.3 Mircrocatheters 53
6.4 Guidewires 54
6.5 Guiding Catheters 55
6.6 Intermediate Catheters 56
6.7 Accessories 57
7 Europe Transradial Access Market, By Application 58
7.1 Overview 59
7.2 Cardiology 61
7.3 Peripheral Vascular 62
7.4 Neurovascular 63
8 Europe Transradial Access Market, By Usage 64
8.1 Overview 65
8.2 Drug Administration 67
8.3 Fluid And Nutrition Administration 69
8.4 Diagnostics And Testing 71
8.5 Blood Transfusion 73
9 Europe Transradial Access Market, By End User 75
9.1 Overview 76
9.2 Hospital 78
9.3 Clinics 79
9.4 Ambulatory Care Centers 80
9.5 Others 81
10 Europe Transradial Access System Market, By Geography 82
10.1 Europe 82
10.1.1 Germany 92
10.1.2 France 97
10.1.3 U.K. 102
10.1.4 Italy 107
10.1.5 Spain 112
10.1.6 Switzerland 117
10.1.7 Netherlands 122
10.1.8 Turkey 127
10.1.9 Belgium 132
10.1.10 Russia 137
10.1.11 Rest Of Europe 142
11 Europe Transradial Access Market, Company Landscape 143
11.1 Company Share Analysis; Europe 143
12 Company Profiles 144
12.1 Cardinal Health 144
12.1.1 Company Overview 144
12.1.2 Revenue Analysis ; Cardinal Health 144
12.1.3 Product Portfolio 145
12.1.4 Recent Developments Recent Developments 146
12.2 Stryker 147
12.2.1 Company Overview 147
12.2.2 Revenue Analysis; Stryker 147
12.2.3 Product Portfolio 148
12.2.4 Recent Developments 148
12.3 Angiodynamics Inc 149
12.3.1 Company Overview 149
12.3.2 Revenue Analysis ; Angiodynamics Inc 149
12.3.3 Product Portfolio 150
12.3.4 Recent Developments 150
12.4 Bd 151
12.4.1 Company Overview 151
12.4.2 Revenue Analysis ; Bd 151
12.4.3 Product Portfolio 152
12.4.4 Recent Developments 152
12.5 Amecath 153
12.5.1 Company Overview 153
12.5.2 Company Snapshot; Amecath 153
12.5.3 Product Portfolio 154
12.5.4 Recent Developments 154
12.6 Boston Scientific Corporation 155
12.6.1 Company Overview 155
12.6.2 Revenue Analysis ; Boston Scientific Corporation 155
12.6.3 Product Portfolio 156
12.6.4 Recent Developments 156
12.7 Edwards Lifesciences Corporation 157
12.7.1 Company Overview 157
12.7.2 Revenue Analysis ; Edwards Lifesciences Corporation 157
12.7.3 Product Portfolio 158
12.7.4 Recent Developments 158
12.8 Medtronic 159
12.8.1 Company Overview 159
12.8.2 Revenue Analysis ; Medtronic 159
12.8.3 Product Portfolio 160
12.8.4 Recent Developments 160
12.9 Merit Medical Systems Inc. 161
12.9.1 Company Overview 161
12.9.2 Revenue Analysis; Merit Medical Systems Inc. 161
12.9.3 Product Portfolio 162
12.9.4 Recent Developments 162
12.10 Nipro Corporation 163
12.10.1 Company Overview 163
12.10.2 Revenue Analysis ; Nipro Corporation 163
12.10.3 Product Portfolio 164
12.10.4 Recent Developments 164
12.11 Oscor Inc 165
12.11.1 Company Overview 165
12.11.2 Company Snapshot; Oscor Inc; 165
12.11.3 Roduct Portfolio 165
12.11.4 Recent Developments 166
12.12 Penumbra 167
12.12.1 Company Overview 167
12.12.2 Revenue Analysis; Penumbra 167
12.12.3 Product Portfolio 168
12.12.4 Recent Developments 168
12.13 Smiths Group Plc 169
12.13.1 Company Overview 169
12.13.2 Revenue Analysis ; Smiths Group Plc 169
12.13.3 Product Portfolio 170
12.13.4 Recent Developments 170
12.14 Teleflex Incorporated 171
12.14.1 Company Overview 171
12.14.2 Revenue Analysis ; Teleflex Incorporated 171
12.14.3 Product Portfolio 172
12.14.4 Recent Developments 172
12.15 Terumo Corporation 173
12.15.1 Company Overview 173
12.15.2 Revenue Analysis ; Terumo Corporation 173
12.15.3 Product Portfolio 174
12.15.4 Recent Developments Recent Developments 175
13 Related Reports 176
?